Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer

被引：0
|
作者：
Eun Kyoung Jeon
Hye-Sung Won
Yoon-Ho Ko
In Seok Lee
Tae Ho Hong
Young Kyoung You
Myung Ah Lee
机构：
[1] Seoul St. Mary’s Hospital,Division of Oncology, Department of Internal Medicine
[2] Catholic University,Division of Oncology, Department of Internal Medicine
[3] Uijeongbu St. Mary’s Hospital,Division of Gastroenterology, Department of Internal Medicine
[4] Catholic University,Department of Surgery
[5] Seoul St. Mary’s Hospital,undefined
[6] Catholic University,undefined
[7] Seoul St. Mary’s Hospital,undefined
[8] Catholic University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词：
Pancreatic cancer; Gemcitabine; Erlotinib; Capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1625 / 1630
页数：5
相关论文
共 50 条
  • [21] RANDOMIZED CROSS-OVER AIO PHASE III TRIAL COMPARING GEMCITABINE PLUS ERLOTINIB FOLLOWED BY CAPECITABINE VS. CAPECITABINE PLUS ERLOTINIB FOLLOWED BY GEMCITABINE IN ADVANCED PANCREATIC CANCER
    Boeck, S.
    Vehling-Kaiser, U.
    Waldschmidt, D.
    Kettner, E.
    Maerten, A.
    Winkelmann, C.
    Klein, S.
    Kojouharoff, G.
    Jung, A.
    Heinemann, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 233 - 233
  • [22] A Phase II Trial of Gemcitabine and Erlotinib (GE) plus Proton Chemotherapy (PCT) and Capecitabine and Oxaliplatin (CapOx) for Locally Advanced Pancreatic Cancer
    Coffman, A. R.
    Hsueh, C. T.
    Hernandez, M.
    Mirshahidi, S.
    Wang, J.
    Solomon, N. L.
    Garberoglio, C. A.
    Reeves, M. E.
    Slater, J. D.
    Yang, G. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E599 - E600
  • [23] The biomarkers of gemcitabine and erlotinib treatment in advanced pancreatic cancer
    Irie, Kuniyasu
    Ueno, Makoto
    Kobayashi, Satoshi
    Gouda, Yoshihiro
    Ohkawa, Shinichi
    Manabu, Morimoto
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [24] Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine
    Nakai, Yousuke
    Isayama, Hiroyuki
    Tsujino, Takeshi
    Yoshida, Haruhiko
    Kawabe, Takao
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Sasaki, Takashi
    Ito, Yukiko
    Togawa, Osamu
    Matsubara, Saburou
    Arizumi, Toshihiko
    Sasahira, Naoki
    Hirano, Kenji
    Matsubara, Minoru
    Omata, Masao
    GASTROINTESTINAL ENDOSCOPY, 2007, 65 (05) : AB226 - AB226
  • [25] Severe lung and skin toxicity during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer
    Boeck, Stefan
    Hausmann, Andreas
    Reibke, Roland
    Schulz, Christoph
    Heinemann, Volker
    ANTI-CANCER DRUGS, 2007, 18 (09) : 1109 - 1111
  • [26] Efficacy and Safety of Metallic Stents in Patients With Unresectable Pancreatic Cancer Receiving Gemcitabine
    Nakai, Yousuke
    Isayama, Hiroyuki
    Kawabe, Takao
    Tsujino, Takeshi
    Yoshida, Haruhiko
    Sasaki, Takashi
    Tada, Minoru
    Arizumi, Toshihiko
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Togawa, Osamu
    Ito, Yukiko
    Matsubara, Saburou
    Hirano, Kenji
    Sasahira, Naoki
    Omata, Masao
    PANCREAS, 2008, 37 (04) : 405 - 410
  • [27] Gemcitabine plus erlotinib (GE) followed by capecitabine (C) versus capecitabine plus erlotinib (CE) followed by gemcitabine (G) in advanced pancreatic cancer (APC): A randomized, cross-over phase III trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
    Boeck, S. H.
    Vehling-Kaiser, U.
    Waldschmidt, D.
    Kettner, E.
    Maerten, A.
    Winkelmann, C.
    Klein, S.
    Kojouharoff, G.
    Jung, A.
    Heinemann, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [28] Efficiency of gemcitabine and capecitabine in the treatment of advanced pancreatic cancer
    Zeynalov, R.
    Musayev, I
    Giyasbeyli, S.
    Gasanzadeh, J.
    Dadashova, N.
    Ahadova, N.
    ANNALS OF ONCOLOGY, 2007, 18 : VII117 - VII117
  • [29] Phase I Trial of Gemcitabine Combined with Capecitabine and Erlotinib in Advanced Pancreatic Cancer: A Clinical and Pharmacological Study
    Francois, E.
    Bennouna, J.
    Chamorey, E.
    Etienne-Grimaldi, M. C.
    Renee, N.
    Senellart, H.
    Michel, C.
    Follana, P.
    Mari, V.
    Douillard, J. Y.
    Milano, G.
    CHEMOTHERAPY, 2012, 58 (05) : 371 - 380
  • [30] A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer
    Oh, D.
    Lee, K.
    Lee, K.
    Sohn, C.
    Zang, D.
    Ryoo, H.
    Song, H.
    Kim, J.
    Bang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345